Dr. Viken L Babikian

M.D. | Neurology


  725 Albany St, Shapiro 7, Suite B, Boston
     Massachusetts, 02118-2526
  617-638-8456    617-638-8465 Maps & Directions
Dr. Viken L Babikian is a Boston, Massachusetts based neurologist who is specialized in Neurology. His current practice location is 725 Albany St, Shapiro 7, Suite B, Boston. Patients can reach him at 617-638-8456 or can fax him at 617-638-8465. Dr. Viken L Babikian is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1013979277.
Dr. Viken L Babikian specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Viken L Babikian speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Viken L Babikian
Specialization: Neurology
Gender:Male
Credentials: M.D.
Practice Address:725 Albany St, Shapiro 7, Suite B, Boston,
Massachusetts, 02118-2526
Phone:617-638-8456
Fax:617-638-8465
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1013979277
NPI Enumeration Date: 04 Apr, 2006
NPI Last Update On: 07 Jul, 2014

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Viken L Babikian
720 Harrison Ave, Dob 503
Boston, Massachusetts
Zip: 02118-2371
Patients can reach Dr. Viken L Babikian at 725 Albany St, Shapiro 7, Suite B, Boston, Massachusetts or can call to book an appointment on 617-638-8456.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.